Acorda Therapeutics
ACOR
ACOR was delisted on the 11th of April, 2024.
148 hedge funds and large institutions have $1.32B invested in Acorda Therapeutics in 2013 Q2 according to their latest regulatory filings, with 148 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
475% more call options, than puts
Call options by funds: $14.7M | Put options by funds: $2.56M
Top Buyers
Top Sellers
ACOR Hedge Fund Activity: Q2 2013 in Review
148 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2013, worth a combined $1.32B.
Buyers outnumbered sellers: 148 funds opened new ACOR positions and 0 closed out — a net gain of 148 holders — while 0 added to existing stakes and 0 trimmed.
- 148 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.32B of Acorda Therapeutics stock for Q2 2013.
- 148 funds opened new Acorda Therapeutics positions in Q2 2013 and 0 closed out, a net change of +148 holders.
Based on aggregated 13F filings for Q2 2013.